Biliopancreatic diversion in a renal transplant patient.
Surgery is usually the only solution to modify the evolution of morbid obesity and resolve the associated co-morbidities. There is very little written regarding malabsorptive surgery and transplantation. A 48-year-old male with hypertension, hyperuricemia and obesity underwent renal transplantation in 1994 for renal amyloidosis. He was maintained on oral immunosuppressive cyclosporine. The patient developed uncontrollable hypertension, hyperlipemia, hyperglycemia and increasing weight to a BMI of 44. Thus, in December 2004, he underwent biliopancreatic diversion (BPD). After 18 months follow-up, he has lost 85% of his excess weight, and his hypertension, hyperglycemia and hyperlipemia are markedly improved. Renal function was not modified, nor were the levels of cyclosporine. He has had no complications derived from the BPD, and has a better quality of life.
López Deogracias
Maite
M
Department of General Surgery, Hospital Marques de Valdecilla, Santander, Spain. cgddda@humv.es
Domínguez-Diez
Agustin
A
Palomar-Fontanet
Rosa
R
González-Noriega
Monica
M
Rodrigo
E
E
Fernández-Fresnedo
G
G
Zubimendi
J A
JA
Olmedo
Francisco
F
Gómez-Fleitas
Manuel
M
Arias
M
M
Fernández-Escalante
Carlos
C
D000686:Amyloidosis / Q000601:surgery; D015904:Biliopancreatic Diversion; D016572:Cyclosporine / Q000008:administration & dosage; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*
D007166:Immunosuppressive Agents; D016572:Cyclosporine